A predictive test for Huntington's disease: recombinant DNA technology and implications for nursing

Area of Science:

• Genetics
• Neuroscience
• Biotechnology

Background:

• Huntington's disease is a neurodegenerative disorder with a known genetic basis.
• Advances in recombinant deoxyribonucleic acid (DNA) technology have revolutionized genetic research.
• Identifying genetic markers is crucial for understanding and diagnosing inherited neurological conditions.

Purpose of the Study:

• To examine the application of recombinant DNA technology in identifying genetic markers for neurogenetic diseases.
• To discuss the ethical, social, and psychological implications of presymptomatic and prenatal genetic testing.
• To explore the role of nursing in supporting clients undergoing genetic testing for neurogenetic disorders.

Main Methods:

• Utilized recombinant DNA technology to locate a genetic marker for Huntington's disease.
• Applied similar approaches to identify gene markers for Alzheimer's disease and manic-depressive illness.
• Reviewed ethical and social issues associated with predictive genetic testing.

Main Results:

• Successfully identified a genetic marker for Huntington's disease.
• Enabled the identification of presymptomatic individuals at risk for Huntington's disease.
• Facilitated the discovery of gene markers for Alzheimer's disease and manic-depressive illness, suggesting broader applicability.

Conclusions:

• Clinical genetic tests for neurogenetic diseases are anticipated to become widely available.
• Presymptomatic and prenatal genetic testing present significant ethical, social, and psychological challenges.
• Nurses require a comprehensive understanding of genetic testing technologies and their implications to effectively support patients.